Toxicities Associated with 1-month Treatment with Propylthiouracil (PTU) and Methimazole (MMI) in Male Rats

Toxicologic Pathology

Volumn 42, Issue 6, 2014, Pages 970-983

  Nambiar, Prashant R ^a   Palanisamy, Gopinath S ^a   Okerberg, Carlin ^a   Wolford, Angela ^a   Walters, Karen ^a   Buckbinder, Leonard ^a   Reagan, William J ^a  

^a PFIZER INC   (United States)

Author keywords

male endocrine system; methimazole; propylthiouracil; rat pathology; rodents; thyroid toxicity; toxicity; toxicology

Indexed keywords

PROPYLTHIOURACIL; THIAMAZOLE;

ANIMAL; BLOOD; CHEMISTRY; DRUG EFFECTS; MALE; PATHOLOGY; RAT; TESTIS; THYROID GLAND; TOXICITY TESTING; WISTAR RAT;

ANIMALS; MALE; METHIMAZOLE; PROPYLTHIOURACIL; RATS; RATS, WISTAR; TESTIS; THYROID GLAND; TOXICITY TESTS;

EID: 84905820447     PISSN: 01926233     EISSN: 15331601     Source Type: Journal    
DOI: 10.1177/0192623313502708     Document Type: Article

References (41)

1. Abou-Auda H. S. Abou-Shaaban R. R. A. (2006). Effect of abouthiouline, a novel drug with therapeutic potential as antithyroid, on some biochemical and hematologic parameters in mice and rats. Saudi Pharm J 14, 34–41.
2. Alexander N. M. (1959). Iodide peroxidase in rat thyroid and salivary glands and its inhibition by antithyroid compounds. J Biol Chem 234, 1530–33.
3. Amara I. B. Hakim A. Troudi A. Soudani N. Makni F. A. Zeghal K. M. Zeghal N. (2011). Protective effects of selenium on methimazole-induced anemia and oxidative stress in adult rats and their offspring. Hum Exp Toxicol 30, 1549–60.
4. Aranda A. Montoya E. Herrera E. (1972). Effects of hypo- and hyper-thyroidism on liver composition, blood glucose, ketone bodies and insulin in the male rat. Biochem J 128, 597–604.
5. E.B., Astwood, Landmark article May 8, 1943: Treatment of hyperthyroidism with thiourea and thiouracil. By E.B. Astwood, JAMA, (1984), 251, 1743-1746
6. Bahn R. S. Burch H. S. Cooper D. S. Garber J. R. Greenlee C. M. Klein I. L. Laurberg P. McDougall I. R. Rivkees S. A. Ross D. Sosa J. A. Stan M. N. (2009). The role of propylthiouracil in the management of Graves’ disease in adults: Report of a meeting jointly sponsored by the American thyroid association and the food and drug administration. Thyroid 19, 673–74.
7. Bandyopadhyay U. Biswas K. Banerjee R. K. (2002). Extrathyroidal actions of antithyroid thionamides. Toxicol Lett 128, 117–27.
8. Bonaci-Nikolic B. Nikolic M. M. Andrejevic S. Zoric S. Bukilica M. (2005). Antineutrophil cytoplasmic antibody (ANCA)-associated autoimmune diseases induced by antithyroid drugs: Comparison with idiopathic ANCA vasculitides. Arthritis Res Ther 7, R1072–81.
9. Bradley S. E. Stephan F. Coelho J. B. Reville P. (1974). The thyroid and the kidney. Kidney Int 6, 346–65.
10. Chiao Y. C. Chao H. L. Huang S. W. Wang P. S. (2000). Direct effects of propylthiouracil on testosterone production in monkeys. Chin J Physiol 43, 55–59.
11. Cooper D. S. (1986). Which anti-thyroid drug? Am J Med 80, 1165–68.
12. Cooper D. S. (2005). Antithyroid drugs. N Engl J Med 352, 905–17.
13. Criswell K. A. Bleavins M. R. Zielinski D. Zandee J. C. Walsh K. M. (1998). Flow cytometric evaluation of bone marrow differentials in rats with pharmacologically induced hematologic abnormalities. Cytometry 32, 18–27.
14. Dixon R. M. Reid S. W. Mooney C. T. (1999). Epidemiological, clinical, haematological and biochemical characteristics of canine hypothyroidism. Vet Rec 145, 481–87.
15. Duncan J. R. Prasse K. W. (1986). Veterinary Laboratory Medicine: Clinical Pathology. Iowa State University Press, Ames, IA.
16. Emiliano A. B. Governale L. Parks M. Cooper D. S. (2010). Shifts in propylthiouracil and methimazole prescribing practices: Antithyroid drug use in the United States from 1991 to 2008. J Clin Endocrinol Metab 95, 2227–33.
17. Everds N. E. Snyder P. W. Bailey K. L. Bolon B. Creasy D. M. Foley G. L. Rosol T. J. Sellers T. (2013). Interpreting stress responses during routine toxicity studies: A review of the biology, impact, and assessment. Toxicol Pathol 41, 560–614.
18. Hallquist A. Hardell L. Degerman A. Boquist L. (1994). Thyroid cancer: Reproductive factors, previous diseases, drug intake, family history and diet. A case-control study. Eur J Cancer Prev 3, 481–88.
19. Johnson L. E. (2008). The Merck manual. In Electrolyte Balance—Phosphate (Porter R. S. Kaplan J. L., eds.). Merck Sharp & Dohme Corp. Whitehouse Station, NJ.
20. Kimura T. Furudate S. (1996). Pituitary GH and prolactin deficiency and testis enlargement in hypothyroid rats caused by goitrogen methimazole. Exp Anim 45, 369–75.
21. Levin S. Semler D. Ruben Z. (1993). Effects of two weeks of feed restriction on some common toxicologic parameters in Sprague-Dawley rats. Toxicol Pathol 21, 1–14.
22. Mantan M. Mishra D. (2010). Congenital hypothyroidism and nephrocalcinosis. Indian Pediatr 47, 281.
23. Maran R. R. (2003). Thyroid hormones: Their role in testicular steroidogenesis. Arch Androl 49, 375–88.
24. Maran R. R. Ravichandran K. Arunakaran J. Aruldhas M. M. (2001). Impact of neonatal hypothyroidism on Leydig cell number, plasma, and testicular interstitial fluid sex steroids concentration. Endocr Res 27, 119–41.
25. Mason R. L. Hunt H. M. Hurxthal L. (1930). Blood cholesterol values in hyperthyroidism and hypothyroidism—Their significance. N Engl J Med 203, 1273–1278.
26. Mendis-Handagama S. M. Siril Ariyaratne H. B. (2005). Leydig cells, thyroid hormones and steroidogenesis. Indian J Exp Biol 43, 939–62.
27. Methimazole. (2001). IARC monograph 79, 53–74. Accessed in 2012 from http://monographs.iarc.fr/ENG/Monographs/vol79/index.php.
28. Ogawa Y. Matsumoto K. Kamata E. Ikeda Y. Kaneko T. (1985). Effect of feed restriction on the peripheral blood and bone marrow cell counts of Wistar rats. Jikken Dobutsu 34, 407–16.
29. Owen N. V. Worth H. M. Kiplinger G. F. (1973). The effects of long-term ingestion of methimazole on the thyroids of rats. Food Cosmet Toxicol 11, 649–53.
30. Propylthiouracil. (2001). IARC monograph 79, 91–125. http://monographs.iarc.fr/ENG/Monographs/vol79/index.php
31. Rehm S. White T. E. Zahalka E. A. Stanislaus D. J. Boyce R. W. Wier P. J. (2008). Effects of food restriction on testis and accessory sex glands in maturing rats. Toxicol Pathol 36, 687–94.
32. Rivkees S. A. (2006). The treatment of Graves’ disease in children. J Pediatr Endocrinol Metab 19, 1095–111.
33. Rivkees S. A. Mattison D. R. (2009). Propylthiouracil (PTU) hepatoxicity in children and recommendations for discontinuation of use. Int J Pediatr Endocrinol 2009, 132041.
34. Rivkees S. A. Stephenson K. Dinauer C. (2010). Adverse events associated with methimazole therapy of Graves’ disease in children. Int J Pediatr Endocrinol 2010, 176970.
35. Roberts G. (1994). Levamisole. In WHO Food Additives Series 33: Evaluation of Certain Veterinary Drug Residues in Food (p. 805). World Health Organization, Canberra, Australia.
36. Ron E. Kleinerman R. A. Boice J. D. Jr LiVolsi V. A. Flannery J. T. Fraumeni J. F. Jr (1987). A population-based case-control study of thyroid cancer. J Natl Cancer Inst 79, 1–12.
37. Russo M. W. Galanko J. A. Shrestha R. Fried M. W. Watkins P. (2004). Liver transplantation for acute liver failure from drug induced liver injury in the United States. Liver Transpl 10, 1018–23.
38. Sitar D. S. Thornhill D. P. (1972). Propylthiouracil: Absorption, metabolism and excretion in the albino rat. J Pharmacol Exp Ther 183, 440–8.
39. Sitar D. S. Thornhill D. P. (1973). Methimazole: Absorption, metabolism and excretion in the albino rat. J Pharmacol Exp Ther 184, 432–39.
40. Wolford A. McDonald T. S. Eng H. Hansel S. Chen Y. Bauman J. Sharma R. Kalgutkar A. S. (2012). Immune-mediated agranulocytosis caused by the cocaine adulterant levamisole: A case for reactive metabolite(s) involvement. Drug Metab Dispos 40, 1067–75.
41. Zachary J. F. McGavin M. D. (2012). Pathologic Basis of Veterinary Disease. Elsevier, St. Louis, MO.